WELLS FARGO & COMPANY/MN - ELOXX PHARMACEUTICALS INC ownership

ELOXX PHARMACEUTICALS INC's ticker is and the CUSIP is 29014R202. A total of 19 filers reported holding ELOXX PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of ELOXX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$5,637
+24.1%
1,172
+0.3%
0.00%
Q2 2023$4,544
+55.1%
1,168
+0.1%
0.00%
Q1 2023$2,929
+37.9%
1,1670.0%0.00%
Q4 2022$2,1241,1670.00%
Other shareholders
ELOXX PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
SILVERARC CAPITAL MANAGEMENT, LLC 54,075$260,1010.08%
AMERICAN FINANCIAL GROUP INC 37,000$1780.06%
ARMISTICE CAPITAL, LLC 275,000$1,322,7500.02%
Atom Investors LP 10,638$51,1690.01%
Altshuler Shaham Ltd 25,123$120,8420.00%
MENORA MIVTACHIM HOLDINGS LTD. 52,355$251,8280.00%
Clal Insurance Enterprises Holdings Ltd 13,526$650.00%
WELLS FARGO & COMPANY/MN 1,172$5,6370.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 19,588$93,2640.00%
View complete list of ELOXX PHARMACEUTICALS INC shareholders